Morberg D. John's Insider Trades & SAST Disclosures
Morberg D. John's most recent trade in Lifecore Biomedical Inc was a trade of 17,500 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Morberg D. John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Morberg D. John | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 17,500 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Morberg John D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 17,500 | 131,900 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John Morberg D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Jan 2024 | 6,283 | 125,617 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 50,000 | 114,400 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 45,000 | 64,400 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 13,500 | 13,500 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 12,591 | 13,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 409 | 409 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 40,229 | 40,229 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 9,771 | 9,771 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 5,123 | 5,123 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 59,254 | 59,254 | - | - | Non-Qualified StockOption (right to buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 5,746 | 5,746 | - | - | Incentive Stock Option (right to buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.05 per share. | 19 Apr 2021 | 2,000 | 19,400 (0%) | 0% | 11.1 | 22,100 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.08 per share. | 16 Apr 2021 | 2,000 | 17,400 (0%) | 0% | 11.1 | 22,160 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.98 per share. | 15 Apr 2021 | 2,000 | 15,400 (0%) | 0% | 11.0 | 21,960 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.64 per share. | 14 Apr 2021 | 2,000 | 13,400 (0%) | 0% | 10.6 | 21,280 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.18 per share. | 13 Apr 2021 | 2,000 | 11,400 (0%) | 0% | 10.2 | 20,360 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.88 per share. | 11 Feb 2021 | 1,400 | 9,400 (0%) | 0% | 11.9 | 16,632 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.64 per share. | 10 Feb 2021 | 2,000 | 8,000 (0%) | 0% | 11.6 | 23,280 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 12.06 per share. | 09 Feb 2021 | 2,000 | 6,000 (0%) | 0% | 12.1 | 24,120 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.97 per share. | 08 Feb 2021 | 2,000 | 4,000 (0%) | 0% | 11.0 | 21,940 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.87 per share. | 05 Feb 2021 | 2,000 | 2,000 (0%) | 0% | 10.9 | 21,740 | Common Stock |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 78,742 | 78,742 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 21,258 | 21,258 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | John D. Morberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 17,500 | 17,500 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges